Cargando…

Transcriptional blood signatures for active and amphotericin B treated visceral leishmaniasis in India

Amphotericin B provides improved therapy for visceral leishmaniasis (VL) caused by Leishmania donovani, with single dose liposomal-encapsulated Ambisome providing the best cure rates. The VL elimination program aims to reduce the incidence rate in the Indian subcontinent to <1/10,000 population/y...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fakiola, Michaela, Singh, Om Prakash, Syn, Genevieve, Singh, Toolika, Singh, Bhawana, Chakravarty, Jaya, Sundar, Shyam, Blackwell, Jenefer M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2019
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6713396/ https://www.ncbi.nlm.nih.gov/pubmed/31419223 http://dx.doi.org/10.1371/journal.pntd.0007673

Ejemplares similares

Genetics, Transcriptomics and Meta-Taxonomics in Visceral Leishmaniasis
por: Blackwell, Jenefer M., et al.
Publicado: (2020)

Current challenges in treatment options for visceral leishmaniasis in India: a public health perspective
por: Singh, Om Prakash, et al.
Publicado: (2016)

Quantitative PCR in Epidemiology for Early Detection of Visceral Leishmaniasis Cases in India
por: Sudarshan, Medhavi, et al.
Publicado: (2014)

Determinants for progression from asymptomatic infection to symptomatic visceral leishmaniasis: A cohort study
por: Chakravarty, Jaya, et al.
Publicado: (2019)

Cytokine Responses to Novel Antigens in an Indian Population Living in an Area Endemic for Visceral Leishmaniasis
por: Singh, Om Prakash, et al.
Publicado: (2012)

Meta-taxonomic analysis of prokaryotic and eukaryotic gut flora in stool samples from visceral leishmaniasis cases and endemic controls in Bihar State India
por: Lappan, Rachael, et al.
Publicado: (2019)

Liposomal Amphotericin B and Leishmaniasis: Dose and Response
por: Sundar, Shyam, et al.
Publicado: (2010)

No evidence for association between SLC11A1 and visceral leishmaniasis in India
por: Mehrotra, Sanjana, et al.
Publicado: (2011)

Developments in Diagnosis of Visceral Leishmaniasis in the Elimination Era
por: Singh, Om Prakash, et al.
Publicado: (2015)

Genetic and functional evaluation of the role of CXCR1 and CXCR2 in susceptibility to visceral leishmaniasis in north-east India
por: Mehrotra, Sanjana, et al.
Publicado: (2011)

Modified solid lipid nanoparticles encapsulated with Amphotericin B and Paromomycin: an effective oral combination against experimental murine visceral leishmaniasis
por: Parvez, Shabi, et al.
Publicado: (2020)

Classification and Regression Tree and Spatial Analyses Reveal Geographic Heterogeneity in Genome Wide Linkage Study of Indian Visceral Leishmaniasis
por: Fakiola, Michaela, et al.
Publicado: (2010)

Immunotherapy and Targeted Therapies in Treatment of Visceral Leishmaniasis: Current Status and Future Prospects
por: Singh, Om Prakash, et al.
Publicado: (2014)

Wuchereria bancrofti infection is associated with progression to clinical visceral leishmaniasis in VL- endemic areas in Muzaffarpur, Bihar, India
por: Singh, Abhishek Kumar, et al.
Publicado: (2023)

Visceral Leishmaniasis in Rural Bihar, India
por: Hasker, Epco, et al.
Publicado: (2012)

Xenodiagnosis to evaluate the infectiousness of humans to sandflies in an area endemic for visceral leishmaniasis in Bihar, India: a transmission-dynamics study
por: Singh, Om Prakash, et al.
Publicado: (2021)

Diagnosis of Visceral Leishmaniasis in an Elimination Setting: A Validation Study of the Diagnostic Algorithm in India
por: Cloots, Kristien, et al.
Publicado: (2022)

Xenodiagnosis to address key questions in visceral leishmaniasis control and elimination
por: Singh, Om Prakash, et al.
Publicado: (2020)

Visceral Leishmaniasis in Muzaffarpur District, Bihar, India from 1990 to 2008
por: Malaviya, Paritosh, et al.
Publicado: (2011)

Diagnosis of Indian Visceral Leishmaniasis by Nucleic Acid Detection Using PCR
por: Srivastava, Pankaj, et al.
Publicado: (2011)

Visceral Leishmaniasis in the Muzaffapur Demographic Surveillance Site: A Spatiotemporal Analysis
por: Hasker, Epco, et al.
Publicado: (2018)

Visceral leishmaniasis: Spatiotemporal heterogeneity and drivers underlying the hotspots in Muzaffarpur, Bihar, India
por: Bulstra, Caroline A., et al.
Publicado: (2018)

Association of Interleukin-18 Gene Polymorphism with Susceptibility to Visceral Leishmaniasis in Endemic Area of Bihar, an Indian Population
por: Kumar, Dinesh, et al.
Publicado: (2014)

Characterization and evaluation of amine-modified graphene amphotericin B for the treatment of visceral leishmaniasis: in vivo and in vitro studies
por: Mudavath, Shyam Lal, et al.
Publicado: (2014)

Visceral leishmaniasis
por: Sundar, Shyam
Publicado: (2015)

Drug Resistance in Leishmaniasis
por: Chakravarty, Jaya, et al.
Publicado: (2010)

Efficacy and Safety of Miltefosine in Treatment of Post-Kala-Azar Dermal Leishmaniasis
por: Sundar, Shyam, et al.
Publicado: (2015)

Post kala-azar dermal leishmaniasis: A threat to elimination program
por: Gedda, Mallikarjuna Rao, et al.
Publicado: (2020)

Cloning, Expression and Purification of L. Donovani Specific Antigen for Serodiagnosis of Visceral Leishmaniasis
por: Kumar, Dinesh, et al.
Publicado: (2013)

Risk Factors for Visceral Leishmaniasis and Asymptomatic Leishmania donovani Infection in India and Nepal
por: Picado, Albert, et al.
Publicado: (2014)

The overexpression of genes of thiol metabolism contribute to drug resistance in clinical isolates of visceral leishmaniasis (kala azar) in India
por: Singh, Neeloo, et al.
Publicado: (2014)

Leishmania Specific CD4 T Cells Release IFNγ That Limits Parasite Replication in Patients with Visceral Leishmaniasis
por: Kumar, Rajiv, et al.
Publicado: (2014)

Serological Markers of Sand Fly Exposure to Evaluate Insecticidal Nets against Visceral Leishmaniasis in India and Nepal: A Cluster-Randomized Trial
por: Gidwani, Kamlesh, et al.
Publicado: (2011)

Strong Association between Serological Status and Probability of Progression to Clinical Visceral Leishmaniasis in Prospective Cohort Studies in India and Nepal
por: Hasker, Epco, et al.
Publicado: (2014)

Visceral Leishmaniasis Elimination Programme in India, Bangladesh, and Nepal: Reshaping the Case Finding/Case Management Strategy
por: Mondal, Dinesh, et al.
Publicado: (2009)

Efficacy and Safety of Paromomycin in Treatment of Post-Kala-Azar Dermal Leishmaniasis
por: Sundar, Shyam, et al.
Publicado: (2014)

Amphotericin B Formulations and Other Drugs for Visceral Leishmaniasis
por: Berman, Jonathan
Publicado: (2015)

Correction: Assessing insecticide susceptibility, diagnostic dose and time for the sand fly Phlebotomus argentipes, the vector of visceral leishmaniasis in India, using the CDC bottle bioassay
por: Chaubey, Rahul, et al.
Publicado: (2023)

Human genetics of leishmania infections
por: Blackwell, Jenefer M., et al.
Publicado: (2020)

Significantly Lower Anti-Leishmania IgG Responses in Sudanese versus Indian Visceral Leishmaniasis
por: Bhattacharyya, Tapan, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_0q13s9hmc2b4l9pl4pvoi9n3bq